Sanofi (SNYNF)
77.48
-1.01
(-1.29%)
USD |
OTCM |
Oct 06, 16:00
Sanofi Enterprise Value : 103.29B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 103.29B |
| October 05, 2026 | 104.52B |
| October 02, 2026 | 103.89B |
| October 01, 2026 | 106.77B |
| September 30, 2026 | 107.28B |
| September 29, 2026 | 106.56B |
| September 28, 2026 | 107.45B |
| September 25, 2026 | 106.30B |
| September 24, 2026 | 108.43B |
| September 23, 2026 | 107.47B |
| September 22, 2026 | 109.77B |
| September 21, 2026 | 112.85B |
| September 18, 2026 | 111.08B |
| September 17, 2026 | 113.03B |
| September 16, 2026 | 113.03B |
| September 15, 2026 | 113.03B |
| September 14, 2026 | 113.03B |
| September 11, 2026 | 111.23B |
| September 10, 2026 | 115.23B |
| September 09, 2026 | 112.44B |
| September 08, 2026 | 114.97B |
| September 04, 2026 | 117.61B |
| September 03, 2026 | 117.61B |
| September 02, 2026 | 116.44B |
| September 01, 2026 | 118.61B |
| Date | Value |
|---|---|
| August 31, 2026 | 118.76B |
| August 28, 2026 | 119.83B |
| August 27, 2026 | 118.09B |
| August 26, 2026 | 118.09B |
| August 25, 2026 | 121.57B |
| August 24, 2026 | 121.57B |
| August 21, 2026 | 122.68B |
| August 20, 2026 | 119.14B |
| August 19, 2026 | 119.14B |
| August 18, 2026 | 118.50B |
| August 17, 2026 | 114.77B |
| August 14, 2026 | 116.18B |
| August 13, 2026 | 114.97B |
| August 12, 2026 | 114.97B |
| August 11, 2026 | 114.91B |
| August 10, 2026 | 113.45B |
| August 07, 2026 | 116.57B |
| August 06, 2026 | 115.21B |
| August 05, 2026 | 110.11B |
| August 04, 2026 | 110.11B |
| August 03, 2026 | 110.98B |
| July 31, 2026 | 111.04B |
| July 30, 2026 | 109.88B |
| July 29, 2026 | 119.47B |
| July 28, 2026 | 117.47B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AstraZeneca PLC | 518.25B |
| GSK Plc | 113.72B |
| Novartis AG | 299.45B |
| Pfizer Inc. | 208.52B |
| Roche Holding AG | -- |
Enterprise Value Related Metrics
| Earnings Yield | 5.01% |
| Operating Earnings Yield | 15.52% |
| Normalized Earnings Yield | 8.868 |